CapsoVision (CV) awards 4,045 RSUs to board director

Rhea-AI Filing Summary

Kuo Hui Ying reported acquisition or exercise transactions in this Form 4 filing.

CapsoVision, Inc. reported that director Kuo Hui Ying received a grant of 4,045 Restricted Stock Units (RSUs), each representing one share of common stock. This is a compensation-related award rather than an open-market trade, and it brings the director’s reported holdings to 4,045 RSUs.

The RSUs vest in two equal parts: 50% on June 30, 2026 and 50% on December 31, 2026, conditioned on continued service on the board through each vesting date. No cash price was paid for the award.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kuo Hui Ying

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit (RSU)	4,045	$0.00	--

Holdings After Transaction: Restricted Stock Unit (RSU) — 4,045 shares (Direct)

Footnotes (1)

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock. These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kuo Hui Ying

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	(1)	03/19/2026		A		4,045		(2)	(2)	Common Stock	4,045	$0	4,045	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. These RSUs are scheduled to vest as to 50% of the RSUs on June 30, 2026 and as to 50% of the RSUs on December 31, 2026 subject to the Non-Employee Director's continued service on the Board through such vesting date.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Hui Ying Kuo	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CapsoVision (CV) disclose in this Form 4?

CapsoVision reported a grant of 4,045 Restricted Stock Units to director Kuo Hui Ying. The award is a stock-based compensation grant, not an open-market purchase or sale, and represents contingent rights to receive common shares over time.

How many CapsoVision (CV) RSUs did the director receive and what do they represent?

The director received 4,045 Restricted Stock Units, each representing a contingent right to one share of CapsoVision common stock. The units convert into shares only as they vest, so they function as deferred stock-based compensation for board service.

When do the newly granted CapsoVision (CV) RSUs vest for the director?

The RSUs vest in two equal tranches: 50% on June 30, 2026 and 50% on December 31, 2026. Vesting is conditioned on the non-employee director continuing to serve on the board through each respective vesting date.

Did the CapsoVision (CV) director buy or sell shares on the market in this filing?

No market buy or sell occurred; this was a compensation grant. The Form 4 shows an acquisition coded as an award of 4,045 RSUs at a zero exercise price, increasing the director’s reported holdings without an open-market transaction.

What is the director’s CapsoVision (CV) position after this RSU grant?

Following the transaction, the filing shows the director holding 4,045 Restricted Stock Units directly. These units correspond to potential future shares of common stock, subject to the vesting schedule and continued board service conditions described in the filing.